A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy
C P Lee(Institute of Cancer Research), Ian Judson(Erasmus Hospital), Alain Oregioni(Institute of Cancer Research), Michael J. Campbell(University of Sheffield), Michaël Tracy(SRI International), David Eaton(Institute of Cancer Research), Kenneth R. Cross(The Honourable Society of Lincoln's Inn), Florence I. Raynaud(Institute of Cancer Research), Ruth Ruddle(Institute of Cancer Research), Martin O. Leach(Engineering and Physical Sciences Research Council), Gavin Halbert(University of Strathclyde), Geoffrey S. Payne, J.P. McNamara(Washington State University), Paul Workman(Institute of Cancer Research), S. Tan(Institute of Cancer Research), Beatrice Seddon(University College London Hospitals NHS Foundation Trust)
Cited by 38
Related Papers
Nonrigid registration using free-form deformations: application to breast MR images
|IEEE Transactions on Medical Imaging|1999|5.3k
Analysis of serial measurements in medical research.
|BMJ|1990|3.2k
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
|Pilot and Feasibility Studies|2016|3k
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k